Related Experiment Videos
Experience with the 'Triple Test' in pancreatic disease
Summary
The Triple Test (TT) effectively screened for pancreatic cancer and chronic pancreatitis, showing abnormal results in most patients with these conditions. This suggests TT is a useful diagnostic tool for pancreatic diseases.
Area of Science:
- Gastroenterology
- Diagnostic Medicine
Background:
- Pancreatic and ampullary cancers present diagnostic challenges.
- Chronic pancreatitis requires accurate and timely diagnosis.
Purpose of the Study:
- To evaluate the efficacy of the Triple Test (TT) as a screening tool for pancreatic and ampullary carcinoma.
- To assess the utility of the TT in differentiating pancreatic diseases from non-pancreatic conditions.
Main Methods:
- Retrospective analysis of the secretin-pancreozymin test, duodenal aspirate cytology, and hypotonic duodenography (the Triple Test).
- Single duodenal intubation procedure performed on patients with pancreatic/ampullary carcinoma, chronic pancreatitis, and non-pancreatic disease.
Main Results:
- The Triple Test yielded abnormal results in 35 out of 36 (97.2%) patients with carcinoma.
- All 11 patients (100%) with chronic pancreatitis showed abnormal TT results.
- 116 out of 170 (68.2%) patients with non-pancreatic disease had normal TT results.
Conclusions:
- The Triple Test demonstrates high sensitivity for detecting pancreatic and ampullary carcinoma.
- The TT is a valuable screening method for identifying patients with chronic pancreatitis.
- The Triple Test shows potential as a useful screening tool for pancreatic diseases.